Highlights of the Annual Press Conference 2014
Video with highlights of the Annual Press Conference on 15 April 2014.
Boehringer Ingelheim presented the results of the business development 2013 and gave an outlook for 2014 at the Annual Press Conference on April 15, 2014 in the Boehringer Ingelheim Center in Ingelheim. The Annual Press Conference 2015 will take place on April 22, 2015.
Our Board Member Allan Hillgrove, Corporate Board Division Pharma Marketing and Sales, will join us on Twitter April 15th to discuss and comment main takeaways of the Annual Press Conference! http://bit.ly/Qcxoma - #BIAPC
Find news and information about our company on our application „Boehringer Ingelheim Corporation“. Now available: our Annual Report 2013 offers the latest information on our business performance and worldwide activities. The app also contains a timeline of Boehringer Ingelheim’s history from 1885 until today. Available on iPad and Android tablet. A short version of the Annual Report 2013 is also available on mobile websites.
Ingelheim, Germany, 15 April 2014 – The research-driven pharmaceutical company Boehringer Ingelheim is pleased with the 2013 financial year. Despite some challenges, the company succeeded in increasing its operating income and the return on net sales. Boehringer Ingelheim generated net sales of around €14.1 billion, which, represents currency-adjusted an increase of 1.4 per cent (- 4.3 per cent in euro terms). This resulted in a 2.4 percentage point improvement in the return on net sales to 15 per cent. For the current financial year, the company expects net sales to remain at a comparable level to that of 2013. Boehringer Ingelheim now employs more 47,400 people worldwide, which is three per cent more than in the previous year.
Chairman of the Board of Managing Directors and Head of Corporate Board Division Pharma Research, Development and Medicine.
Prof. Dr Barner will present the business development 2013 and business perspective 2014 and will give an overview about the Research & Development pipeline.
Head of Corporate Board Division Finance and Animal Health.
Hubertus von Baumbach will present the financial key figures 2013 and will give an overview about the Animal Health business.
Boehringer Ingelheim gives you the right to download images and to duplicate, publish and distribute them for your publishing activities as long as the photo bears the attribution "Image: Boehringer Ingelheim GmbH". Publication details and a voucher copy should be sent to us.
Any kind of changes or partial duplication, publication or distribution of the image are not permitted.
Journalists at the Boehringer Ingelheim Center in Ingelheim, Germany
Prof. Dr Dr Andreas Barner, Corporate Board Divisions Human Resources, Research & Development and Medicine.
For downloading press photos, please visit our Mediapool.